Polynucleotide encoding anti-CD14 antibody fusion protein

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8541565
APP PUB NO 20120277412A1
SERIAL NO

13547548

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A protein comprising (I) an anti-CD14 antibody or its active fragment, or a derivative thereof and (II) an inhibitor for a protease, or its active fragment, or a derivative thereof is provided.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MOCHIDA PHARMACEUTICAL CO LTDTOKYO JAPAN TOKYO METROPOLIS

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Furusako, Shoji Tokyo, JP 32 302
Hosaka, Yoshitaka Tokyo, JP 12 138
Kawahara, Tetsushi Tokyo, JP 9 149
Nakamura, Masaki Tokyo, JP 179 2239
Nakayama, Kazuyuki Tokyo, JP 9 59
Takeuchi, Takashi Tokyo, JP 234 3171

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 24, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00